Patients prescribed popular drugs Ozempic or Wegovy for weight loss or diabetes have a higher risk of developing a potentially blinding eye condition, a study has found.
Researchers at Massachusetts Eye and Ear hospital found that people who were overweight or obese who were prescribed semaglutide, the active ingredient in both drugs, were seven times more likely to be diagnosed with NAION.
